Effects of PALA on the pharmacokinetics of 5-fluorouracil

Oncology Reports

Volumn 5, Issue 1, 1998, Pages 217-221

  Nassim, Mark Adel ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

5 fluorouracil; Leucovorin; N (phosphonacetyl) L aspartate; Pharmacokinetics

Indexed keywords

FLUOROURACIL; SPARFOSIC ACID; THYMIDYLATE SYNTHASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PYRIMIDINE SYNTHESIS; RANDOMIZED CONTROLLED TRIAL;

EID: 6844240198     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.1.217     Document Type: Article

References (2)

1. Pinedo HM and Peters GFJ: Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6: 1653-1664, 1988.
2. Eirlichman C, Fine S, Wong A and Ehakim T: A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6: 469-475, 1988.